Adverse drug reactions (ADRs) rank as one of the top 10 leading causes of death and
illness in developed countries. ADRs show differential features depending upon genotype …

Background: Personalised medicine (PM) is an innovative way to produce better patient
outcomes by using an individualised or stratified approach to disease and treatment rather …

The promise of “personalized medicine” guided by an understanding of each individual's
genome has been fostered by increasingly powerful and economical methods to acquire …

It is anticipated that as the range of drugs for which pharmacogenetic testing becomes
available expands, primary care physicians (PCPs) will become major users of these tests …

Objectives With increasing evidence for the clinical utility of pharmacogenomic (PGx) testing
for depression, there is a growing need to consider issues related to the clinical …

Background: Given their expertise in pharmacotherapy, pharmacists are well positioned to
play a leading role in the implementation of pharmacogenomics in clinical practice …

Introduction: Pharmacogenomic testing can indicate which drugs may have limited
therapeutic action or lead to adverse effects, hence guiding rational and safe prescribing …

One of the basic questions in the early uses of pharmacogenetic (PGx) testing revolves
around the clinical delivery of testing. Because multiple health professionals may play a role …

Background Pharmacogenetic testing enhances patient safety by improving medical
treatment and reducing side effects. It has shown potential in both primary and secondary …

Objectives To evaluate the perceptions of independent community pharmacists within a
regional independent community pharmacy cooperative on implementing personalized …